Global Immunohistochemistry Market Overview
The Global Immunohistochemistry Market report draws accurate insights by examining the latest and prospective industry trends, helping the readers recognize the products and services that are boosting revenue growth and profitability. The study performs a detailed analysis of all the significant factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, prospects, and industry-specific trends. Additionally, the report cites worldwide certainties and endorsements, along with a downstream and upstream evaluation of leading participants.
Market Size – USD 1,736.4 million in 2018, Market Growth - CAGR of 8.6%, Market Trends – Product launches and research for advanced Immunohistochemistry
This report covers the recent COVID-19 incidence and its impact on Immunohistochemistry Market. The pandemic has widely affected the economic scenario. This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.
Check out the Sample Report here: https://www.reportsanddata.com/sample-enquiry-form/2198
The Immunohistochemistry market analysis is intended to provide all participants and vendors with pertinent specifics about growth aspects, roadblocks, threats, and lucrative business opportunities that the market is anticipated to reveal in the coming years. This intelligence study also encompasses the revenue share, market size, production capacity, and rate of consumption to draw insights pertaining to the rivalry to gain control of a large portion of the market share.
Leading Players in the Immunohistochemistry Market:
Abcam plc; Bio SB; Bio-Rad Laboratories Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Merck KGaA;, Inc.; Thermo Fisher Scientific, Inc., PerkinElmer, Agilent Technologies
Competitive landscape
The Immunohistochemistry Industry is extremely competitive and consolidated because of the existence of several established companies that are adopting different marketing strategies in order to increase their market share. The vendors engaged in the sector are outlined based on price, quality, brand, product differentiation, and product portfolio. The vendors are gradually expanding their focus on product personalization by way of customer interaction.
Immunohistochemistry Market segment by :
Type (Revenue, USD Million; 2016–2026)
- Antibodies
- Equipment
- Reagents
- Kits
Application (Revenue, USD Million; 2016–2026)
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
End Use (Revenue, USD Million; 2016–2026)
- Hospitals and Diagnostic Laboratories
- Clinics
- Research Institutes
- Others
Regional Immunohistochemistry Market (Regional Output, Demand & Forecast by Countries):-
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.
Connect with an expert for customization of Report : @ https://www.reportsanddata.com/request-customization-form/2198
Points Covered in The Report:
A. The pivotal aspects considered in the Global Immunohistochemistry Market report consist of the leading competitors functioning in the global sector.
B. The report also encompasses company profiles prominently positioned in the global market.
C. The production, sales, corporate strategies, and the technological capabilities of leading manufacturers are also contained within the report.
D. The driving factors for the growth of the Global Immunohistochemistry Market are explained exhaustively, along with an in-depth account of the end-users in the industry.
E. The report also explains critical application areas of the global sector, curating an accurate description of the market to the readers/users.
F. The report undertakes a SWOT analysis of the market. In the final section, the report features the opinions and views of the industry experts and professionals. The experts also evaluate the export/import policies that might be propelling the growth of the Global Immunohistochemistry Market.
G. The report on the Global Immunohistochemistry Market delivers valuable information for policymakers, investors, stakeholders, service providers, producers, suppliers, and organizations operating in the industry and looking to purchase this research document.
Reasons for Buying Immunohistochemistry Market Report:
A. The report performs an analysis of the dynamic competitive landscape that can help the reader/client move ahead in the global sector.
B. It also presents an in-depth view of the different factors driving or restraining the growth of the global market.
C. The Global Immunohistochemistry Market report provides an eight-year forecast derived on the basis of the potential growth of the market.
D. It helps formulate profitable business decisions by offering thorough insights into the global market and by creating a comprehensive analysis of pivotal market segments and sub-segments.
Access full Report Description, TOC, Table of Figure, Chart, etc. : https://www.reportsanddata.com/report-detail/immunohistochemistry-market
Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions like Asia, United States, Europe, etc.
The global immunohistochemistry market size is expected to reach a value of USD 3.2 billion by 2027, expanding at a CAGR of 7.8%, according to a new report by Radiant Insights, Inc.
IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).
Thus, a rise in the incidence of these chronic diseases has led to an increase in the demand for IHC techniques.
According to 2018 data published by WHO, globally, cancer was one of the leading causes of mortality, and in 2018 around 9.6 million deaths were registered due to cancer.
Additionally, in June 2019, the U.S. FDA approved the expanded use of Agilent Technologies’ PD-L1 IHC 22C3 pharmDx assay for the detection of head and neck squamous cell carcinoma (HNSCC).
This product is used in patients receiving treatment with Merck and Co., Inc.’s Keytruda (Pembrolizumab).
According to the new market research report “Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User – Global Forecast to 2021″, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).Don’t miss out on business opportunities in Immunohistochemistry Market.Speak to our analyst and gain crucial industry insights that will help your business grow:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, at a CAGR of 7.3% during the forecast period.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the market.Immunohistochemistry (IHC) is a laboratory test that uses antibodies to test certain antigens in a tissue combining immunological, anatomical, and biochemical techniques.
There are multiple approaches and permutation in immunohistochemistry applicable in drug testing and diagnosis of chronic diseases like cancer, infectious diseases, cardiovascular diseases, diabetes, and autoimmune diseases.
The market covers the market size from 2014 to 2021.Browse and in-depth TOC on ” Immunohistochemistry Market”181 – Tables44 – Figures225 – PagesRequest for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market.
